|
1
|
Elia-Pasquet S, Provost D, Jaffré A,
Loiseau H, Vital A, Kantor G, Maire JP, Dautheribes M, Darrouzet V,
Dartigues JF, et al: Incidence of central nervous system tumors in
Gironde, France. Neuroepidemiology. 23:110–117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Persano L, Rampazzo E, Basso G and Viola
G: Glioblastoma cancer stem cells: Role of the microenvironment and
therapeutic targeting. Biochem Pharmacol. 85:612–622. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reddy AT and Wellons JC III: Pediatric
high-grade gliomas. Cancer J. 9:107–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perkins SM, Rubin JB, Leonard JR, Smyth
MD, El Naqa I, Michalski JM, Simpson JR, Limbrick DL, Park TS and
Mansur DB: Glioblastoma in children: A single-institution
experience. Int J Radiat Oncol Biol Phys. 80:1117–1121. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bălașa A, Șerban G, Chinezu R, Hurghiș C,
Tămaș F and Manu D: The involvement of exosomes in glioblastoma
development, diagnosis, prognosis, and treatment. Brain Sci.
10:5532020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seymour T, Nowak A and Kakulas F:
Targeting aggressive cancer stem cells in glioblastoma. Front
Oncol. 5:1592015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Anji A and Kumari M: Guardian of genetic
messenger-RNA-binding proteins. Biomolecules. 6:42016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hentze MW, Castello A, Schwarzl T and
Preiss T: A brave new world of RNA-binding proteins. Nat Rev Mol
Cell Biol. 19:327–341. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Muleya V and Marondedze C: Functional
roles of RNA-Binding Proteins in plant signaling. Life. 10:2882020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Idler RK and Yan W: Control of messenger
RNA fate by RNA-binding proteins: An emphasis on mammalian
spermatogenesis. J Androl. 33:309–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Zhang F, Ma J, Ruan X, Liu X, Zheng
J, Liu Y, Cao S, Shen S, Shao L, et al: NCBP3/SNHG6 inhibits GBX2
transcription in a histone modification manner to facilitate the
malignant biological behaviour of glioma cells. RNA Biol. 18:47–63.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gerstberger S, Hafner M and Tuschl T: A
census of human RNA-binding proteins. Nat Rev Genet. 15:829–845.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tailler M, Lindqvist LM, Gibson L and
Adams JM: By reducing global mRNA translation in several ways,
2-deoxyglucose lowers MCL-1 protein and sensitizes hemopoietic
tumor cells to BH3 mimetic ABT737. Cell Death Differ. 26:1766–1781.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okuwaki M, Saito S, Hirawake-Mogi H and
Nagata K: The interaction between nucleophosmin/NPM1 and the large
ribosomal subunit precursors contribute to maintaining the
nucleolar structure. Biochim Biophys Acta Mol Cell Res.
1868:1188792021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yelland JN, Bravo JPK, Black JJ, Taylor DW
and Johnson AW: A single 2′-O-methylation of ribosomal RNA gates
assembly of a functional ribosome. Nat Struct Mol Biol. 30:91–98.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakamura K, Reid BM, Chen A, Chen Z, Goode
EL, Permuth JB, Teer JK, Tyrer J, Yu X, Kanetsky PA, et al:
Functional analysis of the 1p34.3 risk locus implicates GNL2 in
high-grade serous ovarian cancer. Am J Hum Genet. 109:116–135.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, et al: The epidemiology of glioma in adults: a ‘state of the
science’ review. Neuro Oncol. 16:896–913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao H, Ding N, Liao H, Yao Z, Cheng X,
Zhang J and Zhao M: Prediction of relapse and prognosis by
expression levels of long noncoding RNA PEG10 in glioma patients.
Medicine (Baltimore). 98:e175832019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Delgado-López P and Corrales-García E:
Survival in glioblastoma: A review on the impact of treatment
modalities. Clin Transl Oncol. 18:1062–1071. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wohlfart S, Khalansky AS, Gelperina S,
Maksimenko O, Bernreuther C, Glatzel M and Kreuter J: Efficient
chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA
nanoparticles with different stabilizers. PLoS One. 6:e191212011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chow AKM, Yau SWL and Ng L: Novel
molecular targets in hepatocellular carcinoma. World J Clin Oncol.
11:589–605. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chaillou T, Kirby TJ and McCarthy JJ:
Ribosome biogenesis: Emerging evidence for a central role in the
regulation of skeletal muscle mass. J Cell Physiol. 229:1584–1594.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Henras AK, Plisson-Chastang C, O'Donohue
MF, Chakraborty A and Gleizes PE: An overview of pre-ribosomal RNA
processing in eukaryotes. Wiley Interdiscip Rev RNA. 6:225–242.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshida Y, Wang H, Hiwasa T, Machida T,
Kobayashi E, Mine S, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H,
et al: Elevation of autoantibody level against PDCD11 in patients
with transient ischemic attack. Oncotarget. 9:8836–8848. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eid W, Hess D, König C, Gentili C and
Ferrari S: The human exonuclease-1 interactome and phosphorylation
sites. Biochem Biophys Res Commun. 514:567–573. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xing Z, Wang R and Wang X, Liu J, Zhang M,
Feng K and Wang X: CircRNA circ-PDCD11 promotes triple-negative
breast cancer progression via enhancing aerobic glycolysis. Cell
Death Discov. 7:2182021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Williams AJ, Werner-Fraczek J, Chang IF
and Bailey-Serres J: Regulated phosphorylation of 40S ribosomal
protein S6 in root tips of maize. Plant Physiol. 132:2086–2097.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cuperjani F, Gashi L, Kurshumliu F,
Dreshaj S and Selimi F: Relationship between ribosomal protein
S6-pS240 expression and other prognostic factors in non-special
type invasive breast cancer. Breast Care (Basel). 14:171–175. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shirakawa Y, Ohta K, Miyake S, Kanemaru A,
Kuwano A, Yonemaru K, Uchino S, Yamaoka M, Ito Y, Ito N, et al:
Glioma cells acquire stem-like characters by extrinsic ribosome
stimuli. Cells. 10:29702021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mahmoud AB, Ajina R, Aref S, Darwish M,
Alsayb M, Taher M, AlSharif SA, Hashem AM and Alkayyal AA: Advances
in immunotherapy for glioblastoma multiforme. Front Immunol.
13:9444522022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liau LM, Ashkan K, Brem S, Campian JL,
Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, et
al: Association of autologous tumor lysate-loaded dendritic cell
vaccination with extension of survival among patients with newly
diagnosed and recurrent glioblastoma: A phase 3 prospective
externally controlled cohort trial. JAMA Oncol. 9:112–121. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Todo T, Ito H, Ino Y, Ohtsu H, Ota Y,
Shibahara J and Tanaka M: Intratumoral oncolytic herpes virus G47
for residual or recurrent glioblastoma: A phase 2 trial. Nat Med.
28:1630–1639. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen R, Smith-Cohn M, Cohen AL and Colman
H: Glioma subclassifications and their clinical significance.
Neurotherapeutics. 14:284–297. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Quiroga-Artigas G, de Jong D and
Schnitzler CE: GNL3 is an evolutionarily-conserved stem cell gene
influencing cell proliferation, animal growth, and regeneration in
the hydrozoan Hydractinia. Open Biol. 12:2201202022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dong Y, Cai Q, Fu L, Liu H, Ma M and Wu X:
Study of the G protein nucleolar 2 value in liver hepatocellular
carcinoma treatment and prognosis. Biomed Res Int.
2021:48736782021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kang J, Brajanovski N, Chan KT, Xuan J,
Pearson RB and Sanij E: Ribosomal proteins and human diseases:
Molecular mechanisms and targeted therapy. Signal Transduct Target
Ther. 6:3232021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guo P, Wang Y, Dai C, Tao C, Wu F, Xie X,
Yu H, Zhu Q, Li J, Ye L, et al: Ribosomal protein S15a promotes
tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18
expression in hepatocellular carcinoma. Oncogene. 37:1220–1236.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Elhamamsy AR, Metge BJ, Alsheikh HA,
Shevde LA and Samant RS: Ribosome biogenesis: A central player in
cancer metastasis and therapeutic resistance. Cancer Res.
82:2344–2353. 2022. View Article : Google Scholar : PubMed/NCBI
|
